Trial Condition(s):
Hypogonadism, Male
Study to assess safety and pharmacokinetics after repeated i.m. administration of 1000 mg Testosterone Undecanoate in hypogonadal male patients
Bayer Identifier:
90481
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
26
Trial Dates
Phase
2
Could I receive a placebo?
No
Products
Nebido (Testosterone Undeconate, BAY86-5037)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Open-label study to evaluate safety and pharmacokinetic parameters of total and free testosterone after repeated i.m. administration of 1000 mg testosterone undecanoate (5 injections over 36 weeks) in hypogonadal male patients
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
